08048035968
Leading exporter of Genuine LENALID 25MG Capsules from India to Singapore - Tampines | Phoenix Exim

1. General Information

LENALID 25 mg Capsule contains lenalidomide 25 mg, an immunomodulatory medicine related to thalidomide. It is primarily used as part of specialist treatment regimens for certain hematological cancers and disorders.

Lenalidomide is used in conditions including multiple myeloma, certain forms of myelodysplastic syndromes (MDS), and selected lymphomas depending on the approved indication and treatment setting.

It is a prescription-only medicine and should not be started, stopped, or dose-adjusted without medical advice.

2. Product Information

  • Product: LENALID 25 mg Capsule
  • Active ingredient: Lenalidomide
  • Strength: 25 mg
  • Dosage form: Oral capsule
  • Therapeutic category: Immunomodulatory / antineoplastic medicine
  • Administration: Oral
  • Primary therapeutic area: Hematology and oncology

The 25 mg strength is one of the established lenalidomide capsule strengths. The appropriate strength and treatment schedule depend on the disease, other medicines being used, kidney function, blood counts, and the patient's overall clinical condition.

3. Uses of LENALID 25 mg Capsule

Lenalidomide may be prescribed for:

  • Multiple myeloma, commonly in combination with dexamethasone.
  • Maintenance treatment of multiple myeloma following autologous stem-cell transplantation.
  • Transfusion-dependent anemia associated with certain deletion 5q myelodysplastic syndromes.
  • Certain cases of mantle cell lymphoma after previous therapies.
  • Previously treated follicular lymphoma or marginal zone lymphoma in combination with appropriate therapy, depending on the approved indication.

The exact indication varies by country and product authorization.

4. Benefits of This Medicine

When appropriately prescribed, lenalidomide may help:

  • Control or reduce the activity of certain abnormal blood cells.
  • Form an important component of combination treatment for multiple myeloma.
  • Support maintenance treatment after stem-cell transplantation in eligible multiple-myeloma patients.
  • Help manage anemia associated with certain deletion 5q MDS.
  • Provide a treatment option for selected patients with relapsed or previously treated lymphomas.

The expected benefit depends on the patient's diagnosis, disease stage, previous treatment, and response to therapy.

5. Side Effects of LENALID 25 mg

Lenalidomide can cause serious as well as less-serious adverse effects. Important risks include:

  • Decreased white blood cell counts (neutropenia).
  • Decreased platelet counts (thrombocytopenia).
  • Anemia.
  • Increased risk of blood clots, including deep-vein thrombosis and pulmonary embolism.
  • Increased risk of certain arterial cardiovascular events in some treatment settings.
  • Severe skin reactions or hypersensitivity reactions.
  • Liver problems in some patients.
  • Other serious complications requiring medical monitoring.

Seek urgent medical attention for symptoms such as sudden chest pain, difficulty breathing, significant swelling or pain in an arm/leg, or symptoms suggesting a severe allergic reaction.

6. Common Side Effects

Depending on the treatment indication, commonly reported adverse effects can include:

  • Diarrhea
  • Constipation
  • Fatigue
  • Nausea
  • Anemia
  • Neutropenia
  • Thrombocytopenia
  • Rash
  • Muscle cramps or spasms
  • Back pain
  • Abdominal discomfort
  • Reduced appetite
  • Dizziness
  • Headache
  • Cough
  • Upper respiratory infections
  • Peripheral edema

Not every patient experiences these effects, and their severity can vary.

7. How to Use LENALID 25 mg Capsule

Take LENALID exactly according to the oncologist's prescription.

For some adults with multiple myeloma receiving combination therapy, the labeled starting regimen is 25 mg once daily on Days 1–21 of a repeating 28-day cycle. However, this is not a universal dose: dose adjustments may be necessary based on kidney function, blood counts, adverse reactions, treatment indication, and other medicines.

General administration instructions include:

  • Take the capsule orally with or without food, as directed.
  • Swallow the capsule whole with water.
  • Do not crush, chew, or open the capsule.
  • Take it at approximately the same time each day.
  • If you miss a dose, follow your prescribing doctor's instructions rather than taking an extra dose.

8. How LENALID Works

Lenalidomide is an immunomodulatory drug and a thalidomide analogue. It affects the immune system and cellular pathways involved in the survival and growth of abnormal blood cells.

Its actions can include modulation of immune-cell activity and effects on certain cancer-cell processes. In multiple myeloma and other indicated conditions, these effects can contribute to controlling abnormal cells and reducing disease activity.

9. Safety Advice

Pregnancy: Lenalidomide can cause serious birth defects or fetal death. Pregnancy must be excluded before treatment, and strict pregnancy-prevention requirements apply. It should not be used during pregnancy.

Blood counts: Regular blood tests are important because lenalidomide can significantly reduce neutrophils and platelets.

Blood clots: The medicine can increase the risk of DVT and pulmonary embolism, particularly in certain multiple-myeloma treatment combinations. Your doctor may prescribe appropriate thrombosis prevention based on your individual risk.

Kidney function: Lenalidomide is substantially affected by renal function, so the dose may need adjustment in patients with kidney impairment.

Breastfeeding: Breastfeeding is not recommended during treatment.

Drug interactions: Tell your doctor about all medicines and supplements you take. Certain combinations, including some therapies that may increase clotting risk, require particular attention.

Prescription supervision: Lenalidomide should only be obtained and used through appropriate medical and regulatory channels. In the U.S., lenalidomide is subject to a restricted distribution program.

10. FAQs

Q1. What is LENALID 25 mg Capsule?
LENALID 25 mg contains lenalidomide 25 mg, an immunomodulatory prescription medicine used for certain blood cancers and blood disorders.

Q2. Is LENALID 25 mg a chemotherapy medicine?
It is an anticancer medicine, but it belongs to the immunomodulatory drug class rather than traditional cytotoxic chemotherapy.

Q3. What is LENALID 25 mg used for?
It is used in specific treatment settings for multiple myeloma, certain MDS cases, and selected lymphomas.

Q4. Can everyone take LENALID 25 mg?
No. It requires specialist assessment, particularly because of pregnancy risks, blood-count abnormalities, blood-clot risk, and kidney function.

Q5. Can the capsule be opened or crushed?
It should generally be swallowed whole. Follow the product-specific instructions provided by your healthcare professional.

Q6. Does the dose remain 25 mg for every patient?
No. The dose and schedule depend on the indication and individual factors such as kidney function and adverse reactions.

Q7. What should I do if I develop unusual swelling or breathing difficulty?
Seek urgent medical evaluation because these can be warning signs of a blood clot or another serious reaction.

Q8. Is LENALID 25 mg safe during pregnancy?
No. Lenalidomide carries a major embryo-fetal toxicity warning and must not be used during pregnancy.

11. Substitute for LENALID 25 mg

Possible substitutes are other medicines containing lenalidomide 25 mg, including appropriately authorized generic or branded lenalidomide products.

However, a substitute should not be selected solely by matching the strength. The doctor or pharmacist should verify:

  • Active ingredient
  • Strength
  • Manufacturer
  • Regulatory approval
  • Treatment indication
  • Formulation
  • Patient-specific dose and renal requirements

Revlimid (lenalidomide) is the well-known reference brand, while various authorized generic lenalidomide products may also be available depending on the country.

12. Keywords

  • LENALID 25 mg Capsule
  • Lenalidomide 25 mg Capsule
  • LENALID 25 mg exporter from India
  • Lenalidomide 25 mg medicine exporter
  • Lenalidomide capsules supplier India
  • LENALID 25 mg pharmaceutical exporter
  • Lenalidomide 25 mg wholesale supplier
  • Lenalidomide 25 mg for multiple myeloma
  • Lenalidomide 25 mg for MDS
  • Lenalidomide oncology medicine supplier
  • Lenalidomide cancer medicine exporter
  • Lenalidomide 25 mg capsules India
  • LENALID 25 mg supplier Nagpur
  • Pharmaceutical exporter from Nagpur India
  • Medicine exporter from India to USA
  • Medicine exporter from India to UK
  • Medicine exporter from India to Australia
  • Medicine exporter from India to Singapore
  • Medicine exporter from India to Canada
  • Medicine exporter from India to South Korea
  • Medicine exporter from India to UAE
  • Lenalidomide 25 mg international supplier
  • Lenalidomide 25 mg B2B supplier
  • Lenalidomide 25 mg pharmaceutical supplier
  • Lenalidomide 25 mg bulk supply
  • Lenalidomide 25 mg oncology drug supplier
  • LENALID capsules wholesale exporter
  • Lenalidomide 25 mg authorized supply channel
  • Lenalidomide 25 mg prescription medicine supplier
  • Phoenix Exim Lenalidomide supplier
Aug 19th, 2026 12:55 PM

Keywords